(5-Bromopyrazin-2-yl)methanamine
- $90 - $2384
- Product name: (5-Bromopyrazin-2-yl)methanamine
- CAS: 1369140-94-2
- MF: C5H6BrN3
- MW: 188.03
- EINECS:
- MDL Number:MFCD22063120
- Synonyms:(5-Bromopyrazin-2-yl)methanamine;2-Pyrazinemethanamine, 5-bromo-;(5-Bromopyrazin-2-yl)methanamine hydrochloride
5 prices
Selected condition:
Brand
- AK Scientific
- Chemenu
- Crysdot
- TRC
Package
- 2mg
- 250mg
- 1g
- 5g
- ManufacturerAK Scientific
- Product number9802DY
- Product description(5-Bromopyrazin-2-yl)methanamine
- Packaging250mg
- Price$1132
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM334290
- Product description(5-Bromopyrazin-2-yl)methanamine 95%+
- Packaging1g
- Price$2384
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11270808
- Product description(5-Bromopyrazin-2-yl)methanamine 97%
- Packaging5g
- Price$920
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11270808
- Product description(5-Bromopyrazin-2-yl)methanamine 97%
- Packaging1g
- Price$306
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberB422000
- Product description(5-bromopyrazin-2-yl)methanamine
- Packaging2mg
- Price$90
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 9802DY | (5-Bromopyrazin-2-yl)methanamine | 250mg | $1132 | 2021-12-16 | Buy |
Chemenu | CM334290 | (5-Bromopyrazin-2-yl)methanamine 95%+ | 1g | $2384 | 2021-12-16 | Buy |
Crysdot | CD11270808 | (5-Bromopyrazin-2-yl)methanamine 97% | 5g | $920 | 2021-12-16 | Buy |
Crysdot | CD11270808 | (5-Bromopyrazin-2-yl)methanamine 97% | 1g | $306 | 2021-12-16 | Buy |
TRC | B422000 | (5-bromopyrazin-2-yl)methanamine | 2mg | $90 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Danger | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|